Spravato Nasal Spray Approved for Depression

WEDNESDAY, March 6, 2019 — Spravato (esketamine) nasal spray has been approved to treat adult depression in cases where other antidepressants have failed, the U.S. Food and Drug Administration said Tuesday.
The drug’s active ingredient is related…
Source: Topamax